Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2018 Feb 7;200(5):e00611-17. doi: 10.1128/JB.00611-17

Roles of Staphylococcus aureus Mnh1 and Mnh2 Antiporters in Salt Tolerance, Alkali Tolerance, and Pathogenesis

Manisha Vaish a, Alexa Price-Whelan a,*, Tamara Reyes-Robles b, Jun Liu a,*, Amyeo Jereen a, Stephanie Christie a, Francis Alonzo III b, Meredith A Benson b,*, Victor J Torres b, Terry A Krulwich a,
Editor: Olaf Schneewindc
PMCID: PMC5809693  PMID: 29263099

ABSTRACT

Staphylococcus aureus has three types of cation/proton antiporters. The type 3 family includes two multisubunit Na+/H+ (Mnh) antiporters, Mnh1 and Mnh2. These antiporters are clusters of seven hydrophobic membrane-bound protein subunits. Mnh antiporters play important roles in maintaining cytoplasmic pH in prokaryotes, enabling their survival under extreme environmental stress. In this study, we investigated the physiological roles and catalytic properties of Mnh1 and Mnh2 in S. aureus. Both Mnh1 and Mnh2 were cloned separately into a pGEM3Z+ vector in the antiporter-deficient KNabc Escherichia coli strain. The catalytic properties of the antiporters were measured in everted (inside out) vesicles. The Mnh1 antiporter exhibited a significant exchange of Na+/H+ cations at pH 7.5. Mnh2 showed a significant exchange of both Na+/H+ and K+/H+ cations, especially at pH 8.5. Under elevated salt conditions, deletion of the mnhA1 gene resulted in a significant reduction in the growth rate of S. aureus in the range of pH 7.5 to 9. Deletion of mnhA2 had similar effects but mainly in the range of pH 8.5 to 9.5. Double deletion of mnhA1 and mnhA2 led to a severe reduction in the S. aureus growth rate mainly at pH values above 8.5. The effects of functional losses of both antiporters in S. aureus were also assessed via their support of virulence in a mouse in vivo infection model. Deletion of the mnhA1 gene led to a major loss of S. aureus virulence in mice, while deletion of mnh2 led to no change in virulence.

IMPORTANCE This study focuses on the catalytic properties and physiological roles of Mnh1 and Mnh2 cation/proton antiporters in S. aureus and their contributions under different stress conditions. The Mnh1 antiporter was found to have catalytic activity for Na+/H+ antiport, and it plays a significant role in maintaining halotolerance at pH 7.5 while the Mnh2 antiporter has catalytic antiporter activities for Na+/H+ and K+/H+ that have roles in both osmotolerance and halotolerance in S. aureus. Study of S. aureus with a single deletion of either mnhA1 or mnhA2 was assessed in an infection model of mice. The result shows that mnhA1, but not mnhA2, plays a major role in S. aureus virulence.

KEYWORDS: multisubunit cation/proton antiporter I, Staphylococcus aureus, Mnh1, Mnh2, pathogenesis

INTRODUCTION

Staphylococcus aureus is a commensal colonizer of 20 to 30% of healthy people as normal flora of the nasopharynx, skin, and other secondary niches (1). Colonization leads to elevated risk for metastatic S. aureus infections of the host. S. aureus strains cause a large diversity of infections (1, 2). Factors underpinning this diversity include robust stress resilience, biofilm formation, resistance to successive antibiotics, generation of antibiotic-tolerant persisters, and evasion of the host immune response (36). S. aureus not only is prevalent in hospital settings but also has survival efficiency in hostile environments. It successfully survives in high saline up to 25% NaCl, which is commonly found in canned foods. The low water activity (aw) makes the bacteria uniquely resistant to drying and capable of growing and producing enterotoxins in foods with low aw (7, 8). S. aureus lives in highly alkaline (pH up to 9.5) conditions that are found in garden soil, sewage, ground water, and some parts of the human gut (9, 10). Its ability to grow under osmotic and pH stress underpins the ability of S. aureus to thrive in a wide variety of foods, including cured meats that do not support the growth of other foodborne pathogens (11), and is responsible for staphylococcal food poisoning. Such high tolerance of salt and alkaline pH is largely due to the activity of antiporters found in the plasma membrane, which remove toxic cations from the cytoplasm and enable S. aureus to survive under diverse challenging conditions. S. aureus has three families of antiporters called cation/proton antiporters (CPA), namely, CPA1, CPA2, and CPA3. In the present study, we have focused on two homologous, multisubunit cation/proton antiporters of S. aureus, Mnh1 and Mnh2 of the CPA3 family. Most bacterial cation/proton antiporters are the products of single genes encoding a hydrophobic transporter that often functions as a homodimer (12, 13). In contrast, both S. aureus Mnh antiporters are expressed from two different operons, each of which encodes seven genes whose hydrophobic products are designated MnhA to MnhG. The single homologous operon of Listeria monocytogenes also has seven subunits (14), with more sequence homology to S. aureus Mnh1 than to Mnh2. In contrast, some bacteria, e.g., Vibrio cholerae and Pseudomonas aeruginosa, have a six-protein variation in which the first two genes are fused (1517). Both of these hetero-oligomeric antiporter types are categorized in the cation/proton antiporter (CPA) family 3 database, Transport DB (18). These are called Mrp antiporters representing multiple resistances and pH roles (18, 19). Mrp-type antiporters were found initially in alkaliphilic Bacillus halodurans (20), but many nonalkaliphiles have Mrp/Mnh antiporters with roles in pH homeostasis, halotolerance, osmotolerance, and resistance to cholate (15, 2123); P. aeruginosa mrp also supports pathogenesis (16).

Although the Mnh1 antiporter of S. aureus was among the early Mrp-type antiporters described and was shown to catalyze Na+/H+ antiport activity (21), its roles have not been extensively explored. An extensive study showed that S. aureus strains do not have complex I-type NADH oxidoreductases (24). As detailed structural information became available for a bacterial complex I (25), Mopathi and Hägerhäll (26) showed that the Mnh1 antiporter of S. aureus lacks features required to harness a complex I type of electron transport module. They proposed that Mrp-type antiporters are secondary antiporters that are likely progenitors of protein modules that gained the ability to partner with electron transport modules in other bacteria (27, 28). The elevated membrane potential that accompanies activity of an Mnh antiporter is explained by feedback loops. High pH or elevated cation levels increase the demand for proton motive force (PMF) to support the increased cation/proton antiport activity required for pH and/or cation homeostasis. In such instances, increased expression of electron feeders of respiratory chain and/or respiratory components themselves have been observed (29, 30). Finally, a purified Mrp homologue of Mnh antiporters was co-reconstituted in proteoliposomes with an ATPase to establish a PMF and was demonstrated to be functional with no oxidoreductase activity involved (31). The Mnh1 antiporter is thus expected to function as a secondary antiporter that catalyzes PMF-dependent Na+/H+ antiport activity as originally suggested (21). S. aureus strains also have, as already noted, a second Mnh that is designated Mnh2 (17). In this study, the catalytic capacities and physiological roles of the two Mnh antiporters of S. aureus were examined in two S. aureus strains, SH1000 and Newman. Using S. aureus Newman, effects of functional loss of Mnh1 or Mnh2 were also assessed in a murine infection model.

RESULTS

Expression of Mnh1 is largely constitutive while Mnh2 is induced by σB.

The two mnh operons of S. aureus are transcribed in different directions from different loci in the chromosomes. Additionally, while the mnh1 operon consists solely of the seven mnh1 genes, an integrase-recombinase gene (itr) was found to precede the seven mnh2 genes. The S. aureus chromosome encodes six other candidate cation/proton antiporters from three additional antiporter families (CPA1, CPA2, and NhaC). The single CPA2 family member was reported to be a receptor for signaling nucleotide c-di-AMP (32).

A survey of microarray-based gene expression experiments indicated that mnh1 genes are relatively unresponsive to environmental changes (33) (Table 1). In contrast, the mnh2 operon is controlled by σB and is upregulated under stressful conditions, with patterns that often diverge from expression patterns of mnh1 (34, 35).

TABLE 1.

Effects of selected conditions on expression of mnh1 and mnh2 genes, compiled from the Staphylococcus aureus Transcriptome Meta-Database (SATMD)

Gene Relative expression by condition (reference)
Cold shock (59) Stringent response (59) Berberine chloride (60) Alkali (61)a Inorganic acid (61)b 2 M NaCl (41) SigB (35) Fusidic acid (62) Biofilm vs planktonic (63)c
mnhA1
mnhB1
mnhC1
mnhD1
mnhE1
mnhF1
mnhG1
mnhA2
mnhB2
mnhC2
mnhD2
mnhE2
mnhF2
mnhG2
a

Alkali, pH 10 with NaOH.

b

At pH 4 with HCl.

c

At an OD value of 1.0.

We compared expression of mnh1 and mnh2 operon genes in Newman and SH1000 grown in Luria-Bertani broth (LB) without added NaCl or KCl (LB0 medium) until log phase. Expression levels of the mnh1 and mnh2 operon genes were higher in Newman than in SH1000 (Fig. 1). These data sets were analyzed using a quantitative PCR (qPCR) assay on each of the two strains.

FIG 1.

FIG 1

Expression of mnh1 and mnh2 operon genes in S. aureus Newman and SH1000 strains grown in defined LB0 medium with no added salt. Data represent the average of biological triplicates. Error bars represent standard deviations. pyk and fabD were used as a reference genes.

Comparison of catalytic properties and physiological roles of the two Mnh antiporters.

Assays for Mnh antiport activity were conducted in everted (inside out) membrane vesicles of Escherichia coli KNabc, a cation/proton antiporter-deficient strain (Table 2). E. coli KNabc was transformed with either an empty control plasmid or a plasmid expressing either the S. aureus SH1000 mnh1 or mnh2 operon; raw antiporter data are shown in Fig. 2. Mnh1 catalyzed Na+/H+ antiport activity at a pH optimum of 7.5 but still exhibited modest antiport activity at pH 9.0. In contrast, Mnh2 catalyzed Na+/H+ and K+/H+ antiport activity, showing little Na+/H+ antiport and no K+/H+ antiport activity at pH 7.5. As the pH was increased to pH 9.0, increasing Mnh2 antiport activity was observed (Fig. 2), but although not shown, the antiport activity of Mnh2 at pH 9.5 dropped to zero. The profile shown in Table 2 includes the Km for the antiport activities at the optimum pH for each of the two antiporters, pH 7.5 for Mnh1 and pH 9.0 for Mnh2, in the E. coli host used in the assay. The assays shown in Table 3 indicate that if sufficient [Na+] is provided for Mnh2, this antiporter exhibits Na+/H+ antiport activity comparable to that of Mnh1 at pH 7.5, with either succinate or ATP establishing the PMF that energizes the exchange. Cytoplasmic concentrations of K+ in the range of 900 mM are found in S. aureus (36), and this is sufficient to enable Mnh2 to carry out K+/H+ antiport activity even when the antiporter is functioning at a pH significantly below its optimal pH range (Table 3). At such a high concentration of potassium salt in the cytoplasm, the Mnh1 antiporter was inactive, which shows that Mnh2 plays a more important role in osmotolerance. In this study, we report Mnh2 antiport activity for the first time.

TABLE 2.

Activity profile of Mnh1 and Mnh2a

Antiporter and substrate (15 mM) Assay pHb Antiport activity (% dequenching) Km (mM)c
Mnh1: Na+ 7.5 21 ± 1 0.56 ± 0.02
Mnh2
    Na+ 9.0 36 ± 1 0.30 ± 0.01
    K+ 9.0 39 ± 1 0.39 ± 0.21
a

Antiporter assays used 2.5 mM Tris-succinate as the electron donor to the respiratory chain so that a proton motive force, acidic inside, was generated across the everted membrane vesicles. The vesicles were prepared from antiporter-deficient E. coli KNabc transformed with a pGEM3zf+ vector into which either mnh1 or mnh2 was cloned along with a vector control.

b

The antiporter assays were conducted at pH values from pH 7 to pH 9.5. The assay pH that is shown was the pH that yielded the highest activity.

c

The Km (±standard deviation) was calculated at the assay pH shown and is the average from three independent experiments that were conducted with duplicate assays with freshly prepared vesicles prepared from pregrown cells as described in Materials and Methods.

FIG 2.

FIG 2

Antiport activity of Mnh1 and Mnh2. Mnh1 (A and B) and Mnh2 (C and D) were assayed for Na+/H+ and K+/H+ antiport activity, as a function of pH. (E) An empty vector control set of Na+/H+ antiport activity assays was also conducted as a function of pH. Membrane vesicles from pregrown cells were prepared in an inside out orientation relative to the cell membrane from E. coli KNabc cells expressing S. aureus SH1000 mnh1 or mnh2 in pGEM3zf+ vector as described earlier (57). Succinate (2.5 mM) addition initiated PMF generation, as monitored via the quenching of fluorescence of acridine orange, a ΔpH probe present at 1 μM. Antiport activity was assessed from the percent dequenching of acridine orange fluorescence after addition of 10 mM NaCl or KCl. Addition of NH4Cl to each assay abolished residual ΔpH and established a baseline. The tracings shown are representative of assays that were carried out on at least three independent vesicle preparations, with the assays conducted in duplicate for each preparation. A.U., arbitrary units. An empty-vector control set of K+/H+ antiporter assays was also conducted and resulted in no dequenching with KCl addition (data not shown).

TABLE 3.

Mnh1 and Mnh2 antiport activities at pH 7.5a

Antiporter and substrate Concn (mM) Antiport activity (% dequenching)b
Succinate ATP
Mnh1: Na+ 15 21 ± 1 24 ± 1
Mnh2
    Na+ 600 27 ± 2 28 ± 1
    K+ 900 28 ± 3 37 ± 1
a

Antiporter assays were conducted at pH 7.5 using the concentrations of Na+ or K+ indicated, which were determined in preliminary experiments not shown. The efficacies of Tris-succinate and Tris-ATP in providing energy for proton motive force (PMF) generation were compared in each of the duplicate assays conducted in three independent experiments using freshly prepared vesicles from cells that were pregrown as described in Materials and Methods.

b

Succinate generates PMF by donating electrons to the electron transport chain of the antiporter-deficient E. coli KNabc host, while ATP generates PMF by powering the E. coli KNabc F1Fo-ATPase, which directly pumps protons inward in the everted membrane vesicle system.

In order to compare the major physiological contributions of Mnh1 and Mnh2, ΔmnhA1 and ΔmnhA2 single deletion mutants and a double mutant with deletions in both ΔmnhA1 and ΔmnhA2 were constructed in S. aureus SH1000 and Newman. SH1000 had been used in the work that led to the proposal that Mnh was part of a PMF-generating NADH dehydrogenase (37). Deletion of the mnhA gene in SH1000 and Newman completely inactivated Mnh1 and Mnh2, respectively. It was noted that the ΔmnhA1 mutant formed smaller colonies that were hyperpigmented and more orange than the colonies of the staphyloxanthin-containing wild-type strain. A Δmnh1 and Δmnh2 double mutant showed significantly more pigmentation than a Δmnh1 single deletion in SH1000. There was not much difference in the pigment levels of the Δmnh1 and Δmnh1 Δmnh2 strains in Newman (Fig. 3A). The increase in pigment is recognized as a stress response (38, 39). All the strains of SH1000, mutants and wild type, showed more pigmentation than Newman strains (Fig. 3C). The reason for more pigmentation in the SH1000 strain is overexpression of the sigB genes, which also regulates the stress responses. The peaks in absorbance spectra of methanol extracts of the mutant showed a slight shift relative to wild-type spectra (Fig. 3B), suggesting the presence of additional carotenoids that may include staphyloxanthin intermediates (40). No similar carotenoid elevation or shift was observed in the Δmnh2 mutant.

FIG 3.

FIG 3

Carotenoid changes observed in single and double mutants of S. aureus SH1000 and Newman relative to levels in the wild type. (A) Carotenoid measurements for S. aureus SH1000 and Newman wild-type, ΔmnhA1, Δmnh2, and Δmnh1 Δmnh2 strains. (B) Sample absorbance spectra for methanol extracts of S. aureus SH1000 and Newman wild-type and ΔmnhA1, ΔmnhA2, and ΔmnhA1 ΔmnhA2 strains. (C) Radial plating of S. aureus SH1000 and Newman for carotenoid comparison between wild-type and mutant strains. **, P < 0.01 by unpaired t tests between results for the wild-type and ΔmnhA1 strains and between results for the wild-type and ΔmnhA1 ΔmnhA2 strains.

To further explore the roles of the two Mnh antiporters in S. aureus physiology, we studied these antiporters in the commonly used methicillin-susceptible S. aureus strains Newman and SH1000. Growth experiments were conducted in LB0 medium, with no addition of sodium or potassium to the base medium (LB0). As determined by flame photometry, the sodium concentration in LB0 medium was 14.1 mM, and the potassium concentration was 7.3 mM (41).

None of the mutants, not even the ΔmnhA1 ΔmnhA2 mutant, showed a growth defect in LB0 medium at pH 7.5 without added salt, whereas addition of 1 M NaCl resulted in a significant growth defect in the ΔmnhA1 strain and no growth for the double mutant (Fig. 4). Increased pH exacerbated the growth defects both with and without added sodium. No obvious role for the Mnh2 antiporter was observed in coping with addition of 1 M NaCl at pH 7.5 or 8.5 except that the double mutant exhibited a growth deficit relative to the growth of the ΔmnhA1 single mutant at pH 8.5. When 1 M KCl was added instead, no significant defect was observed in the ΔmnhA2 mutant at pH 7.5, but at pH 8.5 there was a significant growth deficit, with the single mutant being almost as impaired as the double mutant. In general, the ΔmnhA1 mutant exhibited less growth inhibition in response to added 1 M KCl than to 1 M NaCl, and the ΔmnhA2 mutant exhibited less growth inhibition in response to added 1 M NaCl than to 1 M KCl. The results were consistent with distinct but partially overlapping roles of the two Mnh antiporters. The ΔmnhA1, ΔmnhA2, and ΔmnhA1 ΔmnhA2 mutant strains were more sensitive to salt and pH stress in the Newman than in the SH1000 background.

FIG 4.

FIG 4

(A) Effects of NaCl and KCl on growth of S. aureus SH1000 (SH) and Newman (NW) wild-type (WT), ΔmnhA1 and ΔmnhA2 mutants, and the ΔmnhA1 ΔmnhA2 double mutant. For the experiments shown in all panels, strains were grown in LB0 medium at 37°C, pH 7.5. Additions of 1 M, 2 M NaCl, and 1 M, 2 M KCl were made, as indicated. (B) The same strains were grown as described for panel A except that the pH was 8.5. (C) For the complementation experiments, the Newman ΔmnhA1 mutant was transformed with the pOS1 vector containing the mnhA1 gene while the ΔmnhA2 strain was transformed with pOS1 containing mnhA2. For the complementation controls, pOS1 with no insert (pOS1::empty) was transformed into each of the three strains (i.e., wild-type, ΔmnhA1, and ΔmnhA2 strains). The growth curves for this and other experiments are the average of three independent experiments in which duplicate assays were conducted; the error bars represent the standard deviations.

The growth patterns of wild-type S. aureus Newman were compared to those of mutants lacking Mnh1 or Mnh2 activity (ΔmnhA1 or ΔmnhA2 strain). Even in the absence of added Na+, there was some growth inhibition of the ΔmnhA1 mutant strain but not of the ΔmnhA2 mutant strain (Fig. 4). In the presence of 2 M NaCl at pH 7.5, the ΔmnhA1 mutant exhibited no growth whereas growth of the ΔmnhA2 strain was unaffected. In the presence of 2 M KCl at pH 7.5, both the ΔmnhA1 and the ΔmnhA2 mutants showed significant growth defects, with the ΔmnhA1 mutant exhibiting a more severe defect than the ΔmnhA2 mutant. Plasmid-based complementation restored the growth of these mutants to the wild-type level under the conditions tested (Fig. 4C).

All efforts to make a clean deletion of the mnhA1 gene in naturally occurring Δmnh2 strains like JE2, LAC, and LAC* failed. However, when we tried to disrupt the mnhA1 gene by introducing a chloramphenicol resistance cassette in ΔmnhA2 Newman, we successfully obtained a double deletion of the Δmnh1 and Δmnh2 genes. JE2, LAC, and LAC* strains showed a phenotype similar to that of the SH1000 and Newman ΔmnhA2 strains (Fig. 5).

FIG 5.

FIG 5

A partial mnh2 deletion in S. aureus JE2 and two related strains leads to a growth defect at high osmolarity that is exacerbated by elevated pH. (Top) The JE2 strain and related LAC and LAC* strains were found by sequencing to have a partial mnh2 deletion that occurred upon a transposition from another chromosomal region. The resulting deletion that includes part of the mnh2 locus extends upstream beyond mnh2 to several more small ORFs. This is shown diagrammatically using the numbering of S. aureus USA300 _FPR3757 so that the numbers up to the displacement correspond to wild-type numbering, without the effect of the deletion from the other segment that relocated. The deletion affecting mnh2 is shown by the missing segment described in the box. (Bottom) Growth curves comparing JE2, LAC, and LAC* to growth of the reference strain, USA300_FPR3757, with and without the addition of 2 M KCl at either pH 7.5 or 8.5. The growth curves are the average of three independent experiments, with the error bars representing the standard deviations.

A transposition that disrupts the mnh2 operon is found in the S. aureus USA300 LAC strains in which Mnh1 was initially suggested to be essential.

Fey et al. (42) reported that the mnh1 genes are candidates for essential genes, based on a screen that was conducted with community-acquired methicillin-resistant S. aureus (CA-MRSA) USA300_LAC derivatives, with the JE2 strain used for transposon mutagenesis. The USA300_FPR3757 genomic sequence (NCBI reference sequence NC_007793) was used as the reference sequence. A critical observation was the absence of some mnh2 genes, along with that of the itr gene of the mhh2 operon and a few small unrelated genes that are usually upstream of the operon. Sequence examinations revealed that these genes were replaced during transposition of an ∼13.1-kb element from another region of the genome into the region containing the mnh2 operon. The transposition resembled but was not completely identical to a transposition reported by Highlander et al. (43) in S. aureus USA300-HOU-MR. We found similar insertions in additional S. aureus strains, with an overall frequency below 5% in the 67 strains that were examined on the NCBI site. The deletion site is shown in Fig. 5 using the framework of the USA300_FPR3757 reference strain, which has intact mnh1 and mnh2 operons so that the sequence numbers retain the wild-type numbering rather than reflect the downstream loss of a transposed element. Growth curves are shown for the reference wild-type strain, S. aureus FPR3757, and three other related strains made for various screens. JE2 is the strain into which the deletions were made in the study of Fey et al. (42), LAC is the parental strain, and LAC* is an erythromycin-sensitive version of LAC. All three strains exhibited sensitivity to 2 M KCl that was exacerbated by elevation of the pH from 7.5 to 8.5 (Fig. 4). This was consistent with loss of Mnh2 function. Multiple attempts to inactivate the intact mnh1 locus in the JE2 and LAC strains were unsuccessful, in contrast to our success in making a double mutant in S. aureus SH1000 and Newman. In the JE2 and LAC strains it is possible that Mnh1 is essential. The viability of the double mutant of Newman shows that mnh1 is not essential. The growth patterns of JE2, LAC, and LAC* were similar to the growth of the Δmnh2 mutant strain of methicillin-sensitive Newman and SH1000.

Mnh1 is required for fitness and pathogenesis in vivo.

To evaluate the contributions of Mnh1 and Mnh2 to S. aureus pathogenesis, mice were infected systematically with isogenic mutants of strain Newman lacking a functional form of either Mnh1 or Mnh2 and compared to a wild-type control with respect to their virulence. The strain with the ΔmnhA2 deletion exhibited virulence similar to that of the wild-type strain, whereas the strain with the ΔmnhA1 deletion showed marked attenuation of virulence (Fig. 6A). To ensure that the phenotype observed was only dependent on the lack of a functional Mnh1 antiporter, a complemented strain was generated by introducing a wild-type copy of mnhA1 into the ΔmnhA1 deletion mutant as a single copy inserted into the SaPI1 site in the chromosome, as had been done previously (44). Expression of the chromosomal wild-type copy of mnhA1 reversed the virulence defect of the strain with the ΔmnhA1 deletion (Fig. 6B). Consistent with the survival data, the ΔmnhA1 deletion mutant exhibited an ∼5-log reduction in bacterial burden in the kidneys of infected mice relative to the level with wild-type Newman (Fig. 6C).

FIG 6.

FIG 6

Mnh1 is required for S. aureus fitness and pathogenesis in vivo. (A) Survival of mice infected intravenously with ∼1 × 107 CFU of the isogenic S. aureus wild-type (n = 10), ΔmnhA1 (n = 10), or ΔmnhA2 (n = 10) strain. (B) Survival of mice infected intravenously with 2 × 107 to 4 × 107 CFU of the isogenic S. aureus ΔmnhA1/SAPI (2.2 × 107 CFU; n = 10) or ΔmnhA1/SAPI::mnhA1 (3.45 × 107 CFU; n = 10) strain. (C) CFU counts from kidneys isolated at the end of the experiment from mice infected with the ΔmnhA1 strain compared to CFU counts from kidneys isolated at ∼96 h postinfection with the wild-type strain. The bar indicates the median. The dotted line indicates the limit of detection.

DISCUSSION

This study confirms that both Mnh1 and Mnh2 of S. aureus are secondary antiporters that catalyze K+ and/or Na+ ion efflux in exchange for H+ ions. The PMF provides the required energy just as well when proton pumping is energized by ATPase activity as when ion pumping via the electron transport chain is involved (Table 3). S. aureus strains are usually able to grow in a range of pHs from pH 5 to at least pH 9 (45) and persist at high osmolarity (41). Mnh1 and Mnh2 have important roles in halotolerance and osmotolerance, respectively (Fig. 4). Nonetheless, they have enough functional overlap that each Mnh can play a critical compensating role in viability when the other Mnh has lost function. Inactivation of Mnh1 by deletion of its first structural gene (mnhA1) resulted in a large reduction in the lethal effects of the wild-type strain in a murine systemic infection mode. Lethality was restored by restoration of a functional mnhA1 into the chromosome (Fig. 6). A comparable deletion of mnh2 in S. aureus Newman did not result in a virulence change. Thus, Mnh1 but not Mnh2 is of interest as a possible new target for incapacitating S. aureus in animal hosts. The Δmnh1 mutant strain is also sensitive to sucrose-generated stress that indicates the osmotolerance of Mnh1 at pH 7.5 to 8.5 (data not shown). Mnh2 would need a high concentration of cytoplasmic K+ in order to carry out K+/H+ antiport activity in the nearly neutral range of pH that is optimal for Mnh1 (Table 2); this contingency is likely to be the rationale for the high cytoplasmic K+ levels that have been found in S. aureus strains (36). Mnh2, which supports osmotolerance, may be a target to consider in the context of packaged-food poisoning by S. aureus strains.

Several screens, with different methodologies (4650), have been carried out to identify genes of diverse S. aureus strains that are essential for fitness in particular settings. The screens with highly stress-resistant S. aureus strains SH1000 and Newman have not shown an essential role for Mnh antiporter genes (47). Fey et al. (42) noted that Mrp antiporter genes of the single Bacillus subtilis Mrp-type antiporter are likely to be essential as they were among the genes that lacked transposon (Tn) insertions in a similar screen. However, we were able to get viable strains with a double deletion of Δmnh1 and Δmnh2 in the Newman strain that suggests that there is leeway. Similarly, a B. subtilis mutant with a full ΔmrpA-mrpG deletion and strains with individual deletions of the B. subtilis mrp genes have already been shown to be viable if the mutants are grown at nearly neutral pH in medium without added sodium ions (19, 51).

In the Pfam database of protein families, Mnh antiporters had, until recently, been grouped together with complex I-type proton pumps under Pfam00361 and identified as oxidored-q1m. Recently, the Pfam curators introduced a distinct Pfam00361 designation, proton_antipo_M, to accommodate Mrp-type secondary antiporters, including Mnh1 and Mnh2, which are independent antiporters that do not carry out redox reactions (52). Another point of confusion had been caused by inconsistent name assignments for the mnh1 and mnh2 antiporters in S. aureus genome annotations. A significant number of mnh2 antiporters are annotated as mnh1 antiporters and vice versa. This should now be easy to correct since the mnh1 operon has only the seven structural genes, and the mnh2 operon can thus be distinguished by its additional integrase-recombinase gene, itr, which precedes the mnh2 structural genes.

MATERIALS AND METHODS

Bacterial strains and their cultures, plasmids, and primers.

The bacterial strains, plasmids, and primers used in this study are listed in Tables 4 and 5.

TABLE 4.

Bacterial strains and plasmids used in this study

Strain or plasmid Description Source or reference
Strains
    Staphylococcus aureus
        SH1000 S. aureus 8325-4 with repaired rsbU 64
        SH1000 ΔmnhA1 Markerless deletion of the mnhA1 gene in SH1000 (locus tag SAOUHSC_00889) This study
        SH1000 ΔmnhA2 Markerless deletion of the mnhA2 gene in SH1000 (locus tag SAOUHSC_00625) This study
        SH1000 ΔmnhA1 ΔmnhA2 Markerless deletion of the mnhA1 and mnhA2 gene in SH1000 This study
        Newman Wild type (clinical isolate) 65
        Newman ΔmnhA (VJT39.95) Markerless deletion of the mnhA1 gene in Newman (locus tag NWMN_0822) This study
        Newman ΔmnhA2 Markerless deletion of the mnhA2 gene in Newman (locus tag NWMN_0593) This study
        FPR3757 Wild type (USA300) 66
        JE2 USA300 (derivative of LAC) 42
        LAC Wild type (USA300) 67
        LAC* USA300 (derivative of LAC) 68
        RN4220 Restriction-deficient intermediate strain 69
        RN9011 RN4220/pRN7023 (SaPI1 integrase, cat194) 44
    Escherichia coli
        KNabc ΔnhaA ΔnhaB ΔchaA (derived from E. coli TG1 70
        DH5α Transformation strain 71
        DH5α-T1R Competent cells for site-directed mutagenesis Invitrogen
Plasmids
    pMAD E. coli/S. aureus shuttle vector 53
    pOS1 S. aureus shuttle vector 72
    pGEM-3Zf(+) Derivative of the pGEM-3Z vector Promega
    pGEMMnh pGEM-3Zf(+) containing the mnh1 operon with putative promoter 30
    pAMPW15 pGEM-3Zf(+) containing the mnh2 operon with putative promoter This study
    pJC1112 SaPI1 attS suicide vector, erythromycin resistant (ermC) 73
    pRN7023 SaPI1 integrase vector, chloramphenicol (cat194) 73

TABLE 5.

Primers used in this study

Function (strain) and primer namea Sequence
mnhA1 deletion (SH1000)
    mnhA1 del 1-1 ATAGGTACCACGCGTATTGGTCCATGTTT
    mnhA1 del 1-2 TGAGTTTGTTACATATTGCGGTGGTGCTTGGTATCGCAGGATT
    mnhA1 del 2-1 AATCCTGCGATACCAAGCACCACCGCAATATGTAA
    mnhA1 del 2-2 ATAGGATCCCAGCCACCATCTGCAAGTT
    mnhA2 deletion (SH1000)
    mnhA2 del 1-1 ATAGGATCCTGTTTCTCCAGTAAGTCGCTCA
    mnhA2 del 1-2 GCTCTAAAGTCACCAAGTATCGCCGCTATGTACCCGGCATATT
    mnhA2 del 2-1 AATATGCCGGGTACATAGCGGCGATACTTGGTGACTTTAGAGC
    mnhA2 del 2-2 ATAGAATTCGACGGTGACGCTGAACATAA
mnhA1 deletion (Newman)
    mnh1-F1369 ATAGGATCCCCACTTTGATTTCACCTTGTTG
    mnhA1 del 2-1 AATCCTGCGATACCAAGCACCACCGCAATATGTAACAAACTCA
    mnh1-R4986 ATAACGCGTCAGTACCATGTTTAAGTCCGCCC
    mnhA1 del 1-2 TGAGTTTGTTACATATTGCGGTGGTGCTTGGTATCGCAGGATT
    mnhA2 deletion (Newman)
    mnh2-F1473 ATAGGATCCGAAGCGCTCAAGATAAAATCTG
    mnhA2 del 1-2 GCTCTAAAGTCACCAAGTATCGCCGCTATGTACCC
    mnh2-R4960 ATAGAATTCCCATACGTTCCCATACTCATAA
    mnhA2 del 2-1 AATATGCCGGGTACATAGCGGCGATACTTGGTGACTTTAGAGC
mnhA1 deletion with CATb gene (Newman)
    mnhA1.UpF_BamH1 ATATAGGATCCGTAGCTATGGTGTCACGA
    mnhA1.UpR_Xho1 ATTTTCGCTCGAGTTAGAGTGCGAATATTAACGG
    CatF_Xho1 ATATACTCGAGCGAAAATTGGATAAAGTGGG
    CatR_kpn1 ATATAGGTACCGTACAGTCGGCATTATCTCA
    mnhA1.DnF_kpn1 ACTGTACGGTACCATCGCAGGATTAGCTGTA
    mnhA1.DnR_EcoR1 ATATAGAATTCGACACTAATTGCTGTGAG
qPCR on mnh1 (SH1000)
    mnhA1 f GCACCCGACTTAGCATTGAC
    mnhA1 r ATGACGGACAAACCAACACC
    mnhB1 f TATACACCTGGTGGCGGTTT
    mnhB1 r CGATAGGCGTCGCAATACA
    mnhC1 f GGCGGACTTAAACATGGTACTG
    mnhC1 r TAAGTGCTTGCGGGATAGGA
    mnhD1 f CCTTCTTCGTAATGGGTGTAGC
    mnhD1 r TCATGCGCTGAAAGGTTAGC
    mnhE1 f GCAGTGTTTTGGTTGTTTGTGAC
    mnhE1 r AACACTCTGTGTAAGAGGTAAACAAGAACTA
    mnhF1 f CATTAGATGCGATTGGTCTTCA
    mnhF1 r TGTTCAATCACCTTACCTTTGTCC
qPCR on mnh2 (SH1000)
    mnhA2 f GCGGATATGCTCAACACCAA
    mnhA2 r TCCCATGAAAAGCGCACA
    mnhB2 f CGTGTTAAGAACGGTCACGAA
    mnhB2 r CAATAAACCCACCACCAGGA
    mnhC2 f GGTTTGGGATGACTGCGTTT
    mnhC2 r CCCTTAGGCCTTCAATTTCATC
    mnhD2 f GTCATCGGCGCTATAGGTGT
    mnhD2 r CCTGCAAACGTGTTTGTTCC
    mnhE2 f ACAGGTTTTTCAGCGATGATTT
    mnhE2 r TCCAGGGTTCATATCTTTTGTTT
    mnhF2 f TCAAGGGACCTACAACAGCA
    mnhF2 r GAAACGGTGCCCATAAGT
a

f, forward; r, reverse.

b

CAT, chloramphenicol acetyltransferase.

Growth conditions.

S. aureus strains were routinely grown in a modified version of Luria-Bertani broth (LB), designated LB0, which is LB without added NaCl or KCl. Cultures were incubated at 37°C with shaking at 225 rpm. For plasmid selection in S. aureus strains, erythromycin was added to the medium at 2.5 μg/ml, and chloramphenicol was added at 10 μg/ml. For growth experiments, a BioTek PowerWave plate reader was used. Overnight cultures were inoculated at an initial optical density at 600 nm (OD600) of 0.01 in a total of 200 μl of LB0, and 60 mM Bis-Tris propane and salt were added as indicated in the legend to Fig. 4. The cultures were adjusted to the desired pH with HCl and distributed in individual wells of 96-well plates. The plates were incubated with continuous shaking on the low setting at 37°C. The growth curves were conducted in three independent experiments in triplicate repeats.

Growth experiments.

Glycerol stocks of S. aureus were inoculated in LB0 medium, pH 7.5, with no salt and grown for 16 h at 37°C with shaking at 225 rpm prior to growth experiments. Overnight cultures were normalized to an OD600 of 0.2 with unbuffered LB0 medium, which contains no Bis-Tris propane and is not pH adjusted. Ten microliters of precultures at an OD600 of 0.2 was passed into 190 μl of corresponding medium in 96-well microplates for a starting OD600 of 0.01 for all growth conditions. Microplate lids were then carefully sealed with 1.2- by 40-cm silicone rubber tape and incubated in 37°C with shaking at 225 rpm in a BioTek PowerWave HT microplate spectrophotometer for 24 h. OD600 readings were collected every hour. Growth curves are averages of at least three independent experiments done in duplicate repeats.

Relative quantitation of staphyloxanthin pigment in wild-type S. aureus SH1000 and Newman and Δmnh mutants.

Staphyloxanthin was extracted from S. aureus cultures using methanol, and relative amounts were quantified by absorbance measurements. Cultures were inoculated at an OD600 of 0.01 in 50 ml of LB0 medium and incubated in a 250-ml flask at 37°C in the dark. After 48 h of incubation, 1,000 μl of culture was removed for OD600 measurements, and 15 ml of culture was centrifuged at 4,500 rpm for 20 min to harvest cells; the pellet was washed twice with sterile water. Excess water was removed, and 1 ml of methanol was added to each cell pellet. The pellets were vortexed to extract the pigment and incubated at 55°C for 20 min in the dark. Pellets were vortexed every 5 min and centrifuged at 4,500 rpm at 4°C after 20 min. Supernatant was collected in a glass tube. The level of carotenoid pigment was estimated quantitatively by measuring the absorbance at a 445-nm wavelength in a Shimadzu UV 1800 spectrophotometer.

Radial spot plating of S. aureus for carotenoid color comparison between strains.

Overnight cultures were incubated at 37°C in LB0 medium, pH 7.5, with no salt and with shaking at 225 rpm. After 16 h of growth, cultures were normalized to an OD600 of 0.2 using LB0 medium, and then 100-fold serial dilutions were made. The following volumes and dilutions were plated on LB0 medium per radial wing from the inner ring for each strain: 5 μl of 10−2 dilutions, 13 μl of 10−4 dilutions, and 30 μl of 10−6 dilutions. The plate was incubated at 37°C for 42 h and left at 4°C for 24 h. After plates were warmed at room temperature, a picture was taken.

Construction of markerless deletions in S. aureus by allelic replacement.

Deletions of target genes, which were done in frame, were generated using pMAD (53) according to previously published methods (54). Briefly, ∼1-kb PCR products on either side of the sequence to be deleted were generated and fused by gene SOEing (55). The 2-kb product was ligated into pMAD and transformed into E. coli. After plasmid isolation and sequence verification, the construct was moved into S. aureus RN4220 by electroporation. After isolation from RN4220, the construct was electroporated into the target S. aureus strain. The plasmid was recombined into the chromosome by inoculating a liquid culture for 2 h at the permissive temperature (28°C), followed by overnight inoculation at the restrictive temperature (42°C) and plating of dilutions on LB0 agar containing erythromycin. Merodiploid clones (containing the plasmid recombined into the chromosome) were verified by PCR. To resolve the plasmid out of the chromosome and to generate candidate deletion mutants, liquid cultures of merodiploids were incubated at 28°C without selection and transferred by 1:100 dilutions for 7 days before being plated on LB0 agar. Candidate mutants were screened for loss of erythromycin resistance (confirming loss of the plasmid), and PCR and sequencing were used to confirm exclusive presence of the deleted allele.

The Newman ΔmnhA1 ΔmnhA2 mutant was not isolated using these methods; instead, a positive-selection method was utilized. The chloramphenicol acetyltransferase gene of 820 kb was amplified from pOS1 and ligated between the PCR products from either side of the mnhA1 sequence to be deleted using gene SOEing (55). The 3-kb product was ligated into pMAD and transformed into E. coli. After plasmid isolation and sequence verification, the construct was moved into S. aureus RN4220 by electroporation. After isolation from RN4220, the construct was electroporated into the target S. aureus Newman ΔmnhA2 strain. Subsequent steps were the same as those described above.

Complementation of markerless deletions.

Plasmids for complementation of the mnhA1 and mnhA2 deletion mutants were constructed using the pOS1 vector. For mnhA1 complementation, an ∼3-kb product was amplified that contained mnhA2 and the upstream open reading frame (ORF) that is predicted to encode an integrase/recombinase and to be coexpressed with the mnh2 operon. This product also contains ∼240 bp of sequence upstream of the gene for the putative integrase/recombinase that includes the binding site for σB, which controls mnh2 expression (35). These products were ligated into pOS1, and the resulting plasmids were transformed into E. coli. After plasmid isolation and sequence verification, the constructs were moved into S. aureus RN4220 by electroporation. After isolation from RN4220, the constructs were electroporated into the appropriate target mutants of S. aureus Newman.

Preparation of total RNA and cDNA from S. aureus Newman and SH1000 strains and relative quantification of RNA transcripts by qPCR.

RNA was prepared according to a method described previously (56). Cultures were inoculated in 50 ml of LB0 medium and grown up to an OD600 of 0.9 at 37°C. Eight milliliters of culture was added to 8 ml of RNA Protect bacteria reagent (Qiagen) in 50-ml sterile tubes and then vortexed immediately for 5 s and incubated at room temperature for 5 min. Cells were harvested by centrifugation (4,700 rpm, 21°C, and 10 min), the supernatant was poured off, and then the tube was inverted on paper towel for 10 s. Pellets were stored at −80°C overnight. The following day, RNA was isolated using an miRNeasy purification kit (Qiagen) for subsequent steps.

cDNA was synthesized using an iScript cDNA synthesis kit (170-8891; Bio-Rad), and each reaction was performed in a final volume using 200 ng of RNA according to the manufacturer's instructions. Relative qPCR was performed in a 384-well plate at the qPCR shared resource facility (Icahn School of Medicine at Mount Sinai, USA). Primers were designed using Primer 3 software. Reactions were set up in a total volume of 10 μl using 5 μl of cDNA (1:50 dilution) and 5 μl of master mix. Thermo cycling conditions were as follows: 2 min at 95°C; 40 cycles of 95°C for 15 s, 55°C for 15 s, and 72°C for 30 s; a final step of 95°C for 15 s, 60°C for 15 s, and 95°C for 15 s. Samples were run in triplicate, and a no-template control and a no-reverse transcriptase control were run to ensure absence of DNA contamination. Data were analyzed using SDS, version 2.2.1, software (Applied Biosystems, USA).

Antiporter assays.

Antiporter assays were conducted in everted membrane vesicles prepared from transformants of the triple antiporter-deficient E. coli KNabc strain expressing the empty vector, pGEM3zf+, or either the mnh1 or mnh2 operon. The everted membrane vesicles are oriented in such a manner that part of the membrane that is exposed outside the bacterial cells comes inside the vesicles. The transformants were grown overnight and then frozen in liquid nitrogen and stored at −80°C. Preparation of vesicles from the E. coli transformants was conducted using a French press as described earlier (57). The vesicles were used immediately after preparation, without being frozen. The assays also followed a protocol used earlier with the same buffer and pH conditions. Acridine orange was the ΔpH probe used, with measurements conducted using an RF-5301 PC Shimadzu spectrofluorophotometer equipped with a stirrer, with excitation at 420 nm and emission at 500 nm (both with a 10-mm slit). When the respiratory chain is energized by succinate, the respiratory chain starts pumping protons inside the vesicles (as vesicles are everted). The initiation of proton motive force generation is indicated for specific experiments.

Pathogenicity assays. (i) Generation of mnhA1 chromosomal integration strains and growth curves for determination of their phenotypes.

To generate isogenic mnhA1 complementation strains, the entire mnh locus was amplified from S. aureus Newman genomic DNA using the oligonucleotide pair VJT1276 (5′-ATATAGGATCCTGAAGCTATATCGATTTTCACACAA-3′) and VJT1277 (5′-ATATAGGTACCAACTGCAGCAAATTGCAAAA-3′) and cloned into the integration vector pJC1112 using BamHI and KpnI restriction sites. The plasmid was transformed into E. coli DH5α and ampicillin resistance-selected clones. A positive recombinant clone was electroporated into RN9011 containing plasmid pRN7023 encoding the SaPI1 integrase to promote single-copy chromosomal integration into the S. aureus SaPI1 site (44) and was selected for erythromycin resistance, as described elsewhere (58). The SaPI1 integrated construct was then transduced into strain VJT39.95 (Newman ΔmnhA1) using previously published methods (58).

(ii) Generation of a pJC1112 control strain.

To generate the pJC1112 (empty vector) control strain, purified plasmid from strain VJT9.54 (E. coli DH5α containing pJC1112) was electroporated into RN9011, followed by transduction into strain VJT39.95 (Newman ΔmnhA1) as described above.

(iii) Murine systemic infection.

Animal infections were done according to protocols approved by the New York University School of Medicine Institutional Animal Care and Use Committee. For in vivo experiments, 5-week-old female ND4 Swiss Webster mice (Harlan Laboratories) were anesthetized with 250 μl of Avertin (2,2,2-tribromoethanol dissolved in tert-amyl-alcohol and diluted to a final concentration of 2.5% [vol/vol] in sterile saline) intraperitoneally. This was followed by retro-orbital injection of 5 × 107 CFU of wild-type S. aureus Newman, isogenic Newman strains with either a single mnhA1 deletion or mnhA2 deletion or with an isogenic Newman mnhA1 deletion strain complemented in single copy with either the integrase-encoding empty vector pJC1112 (ΔmnhA1/pJC1112) or pJC1112 with mnhA1 in the SaPI1 site (ΔmnhA1/pJC1112-mnhA1). Mice were monitored for acute infection and signs of morbidity, at which points mice were sacrificed, and survival curves were plotted over time.

ACKNOWLEDGMENTS

This work was supported by research grant R01GM028454 from the National Institute of General Medical Sciences to T.A.K. and grant R21 AI101533 from the National Institute of Allergy and Infectious Diseases to V.J.T. S.C. was supported by a Postbaccalaureate Research Education Program grant (R25GM06118). V.J.T. is a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Diseases.

We declare that we have no conflicts of interest.

REFERENCES

  • 1.Fitzgerald JR. 2014. Evolution of Staphylococcus aureus during human colonization and infection. Infect Genet Evol 21:542–547. doi: 10.1016/j.meegid.2013.04.020. [DOI] [PubMed] [Google Scholar]
  • 2.Uhlemann AC, Otto M, Lowy FD, DeLeo FR. 2014. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol 21:563–574. doi: 10.1016/j.meegid.2013.04.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Conlon BP, Rowe SE, Lewis K. 2015. Persister cells in biofilm associated infections. Adv Exp Med Biol 831:1–9. doi: 10.1007/978-3-319-09782-4_1. [DOI] [PubMed] [Google Scholar]
  • 4.Moormeier DE, Bose JL, Horswill AR, Bayles KW. 2014. Temporal and stochastic control of Staphylococcus aureus biofilm development. mBio 5:e01341-14. doi: 10.1128/mBio.01341-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Prax M, Bertram R. 2014. Metabolic aspects of bacterial persisters. Front Cell Infect Microbiol 4:148. doi: 10.3389/fcimb.2014.00148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pauli NT, Kim HK, Falugi F, Huang M, Dulac J, Henry Dunand C, Zheng NY, Kaur K, Andrews SF, Huang Y, DeDent A, Frank KM, Charnot-Katsikas A, Schneewind O, Wilson PC. 2014. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J Exp Med 211:2331–2339. doi: 10.1084/jem.20141404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wu X, Su YC. 2014. Effects of frozen storage on survival of Staphylococcus aureus and enterotoxin production in precooked tuna meat. J Food Sci 79:M1554-9. doi: 10.1111/1750-3841.12530. [DOI] [PubMed] [Google Scholar]
  • 8.Mansfield JM, Farkas G, Wieneke AA, Gilbert RJ. 1983. Studies on the growth and survival of Staphylococcus aureus in corned beef. J Hyg (Lond) 91:467–478. doi: 10.1017/S0022172400060514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chao WL, Ding RJ, Chen RS. 1987. Survival of pathogenic bacteria in environmental microcosms. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 20:339–348. [PubMed] [Google Scholar]
  • 10.Aslam S, Sajid I. 2016. Antimicrobial potential of halophilic actinomycetes against multi drug resistant (MDR) ventilator associated pneumonia causing bacterial pathogens. Pak J Pharm Sci 29:367–374. [PubMed] [Google Scholar]
  • 11.Cruz J, Montville TJ. 2008. Influence of nisin on the resistance of Bacillus anthracis Sterne spores to heat and hydrostatic pressure. J Food Prot 71:196–199. doi: 10.4315/0362-028X-71.1.196. [DOI] [PubMed] [Google Scholar]
  • 12.Gerchman Y, Rimon A, Venturi M, Padan E. 2001. Oligomerization of NhaA, the Na+/H+ antiporter of Escherichia coli in the membrane and its functional and structural consequences. Biochemistry 40:3403–3412. doi: 10.1021/bi002669o. [DOI] [PubMed] [Google Scholar]
  • 13.Lee C, Kang HJ, von Ballmoos C, Newstead S, Uzdavinys P, Dotson DL, Iwata S, Beckstein O, Cameron AD, Drew D. 2013. A two-domain elevator mechanism for sodium/proton antiport. Nature 501:573–577. doi: 10.1038/nature12484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bergholz TM, Bowen B, Wiedmann M, Boor KJ. 2012. Listeria monocytogenes shows temperature-dependent and -independent responses to salt stress, including responses that induce cross-protection against other stresses. Appl Environ Microbiol 78:2602–2612. doi: 10.1128/AEM.07658-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Dzioba-Winogrodzki J, Winogrodzki O, Krulwich TA, Boin MA, Hase CC, Dibrov P. 2009. The Vibrio cholerae Mrp system: cation/proton antiport properties and enhancement of bile salt resistance in a heterologous host. J Mol Microbiol Biotechnol 16:176–186. doi: 10.1159/000119547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kosono S, Haga K, Tomizawa R, Kajiyama Y, Hatano K, Takeda S, Wakai Y, Hino M, Kudo T. 2005. Characterization of a multigene-encoded sodium/hydrogen antiporter (Sha) from Pseudomonas aeruginosa: its involvement in pathogenesis. J Bacteriol 187:5242–5248. doi: 10.1128/JB.187.15.5242-5248.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Swartz TH, Ikewada S, Ishikawa O, Ito M, Krulwich TA. 2005. The Mrp system: a giant among monovalent cation/proton antiporters? Extremophiles 9:345–354. doi: 10.1007/s00792-005-0451-6. [DOI] [PubMed] [Google Scholar]
  • 18.Ren Q, Chen K, Paulsen IT. 2007. TransportDB: a comprehensive database resource for cytoplasmic membrane transport systems and outer membrane channels. Nucleic Acids Res 35:D274–D279. doi: 10.1093/nar/gkl925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ito M, Guffanti AA, Oudega B, Krulwich TA. 1999. mrp, a multigene, multifunctional locus in Bacillus subtilis with roles in resistance to cholate and to Na+ and in pH homeostasis. J Bacteriol 181:2394–2402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hamamoto T, Hashimoto M, Hino M, Kitada M, Seto Y, Kudo T, Horikoshi K. 1994. Characterization of a gene responsible for the Na+/H+ antiporter system of alkalophilic Bacillus species strain C-125. Mol Microbiol 14:939–946. doi: 10.1111/j.1365-2958.1994.tb01329.x. [DOI] [PubMed] [Google Scholar]
  • 21.Hiramatsu T, Kodama K, Kuroda T, Mizushima T, Tsuchiya T. 1998. A putative multisubunit Na+/H+ antiporter from Staphylococcus aureus. J Bacteriol 180:6642–6648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jasso-Chavez R, Diaz-Perez C, Rodriguez-Zavala JS, Ferry JG. 2017. Functional role of MrpA in the MrpABCDEFG Na+/H+ antiporter complex from the archaeon Methanosarcina acetivorans. J Bacteriol 199:e00662-16. doi: 10.1128/JB.00662-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Meng L, Meng F, Zhang R, Zhang Z, Dong P, Sun K, Chen J, Zhang W, Yan M, Li J, Abdel-Motaal H, Jiang J. 2017. Characterization of a novel two-component Na+(Li+, K+)/H+ antiporter from Halomonas zhaodongensis. Sci Rep 7:4221. doi: 10.1038/s41598-017-04236-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Spero MA, Aylward FO, Currie CR, Donohue TJ. 2015. Phylogenomic analysis and predicted physiological role of the proton-translocating NADH:quinone oxidoreductase (complex I) across bacteria. mBio 6:e00389-15. doi: 10.1128/mBio.00389-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sazanov LA. 2015. A giant molecular proton pump: structure and mechanism of respiratory complex I. Nat Rev Mol Cell Biol 16:375–388. doi: 10.1038/nrm3997. [DOI] [PubMed] [Google Scholar]
  • 26.Moparthi VK, Hagerhall C. 2011. The evolution of respiratory chain complex I from a smaller last common ancestor consisting of 11 protein subunits. J Mol Evol 72: 484–497. doi: 10.1007/s00239-011-9447-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Marreiros BC, Batista AP, Duarte AM, Pereira MM. 2013. A missing link between complex I and group 4 membrane-bound [NiFe] hydrogenases. Biochim Biophys Acta 1827:198–209. doi: 10.1016/j.bbabio.2012.09.012. [DOI] [PubMed] [Google Scholar]
  • 28.Mayer S, Steffen W, Steuber J, Gotz F. 2015. The Staphylococcus aureus NuoL-like protein MpsA contributes to the generation of membrane potential. J Bacteriol 197:794–806. doi: 10.1128/JB.02127-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Swartz TH, Ito M, Hicks DB, Nuqui M, Guffanti AA, Krulwich TA. 2005. The Mrp Na+/H+ antiporter increases the activity of the malate:quinone oxidoreductase of an Escherichia coli respiratory mutant. J Bacteriol 187:388–391. doi: 10.1128/JB.187.1.388-391.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Swartz TH, Ito M, Ohira T, Natsui S, Hicks DB, Krulwich TA. 2007. Catalytic properties of Staphylococcus aureus and Bacillus members of the secondary cation/proton antiporter-3 (Mrp) family are revealed by an optimized assay in an Escherichia coli host. J Bacteriol 189:3081–3090. doi: 10.1128/JB.00021-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Morino M, Suzuki T, Ito M, Krulwich TA. 2014. Purification and functional reconstitution of a seven-subunit mrp-type Na+/H+ antiporter. J Bacteriol 196:28–35. doi: 10.1128/JB.01029-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Corrigan RM, Campeotto I, Jeganathan T, Roelofs KG, Lee VT, Grundling A. 2013. Systematic identification of conserved bacterial c-di-AMP receptor proteins. Proc Natl Acad Sci U S A 110:9084–9089. doi: 10.1073/pnas.1300595110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Nagarajan V, Elasri MO. 2007. SAMMD: Staphylococcus aureus microarray meta-database. BMC Genomics 8:351. doi: 10.1186/1471-2164-8-351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W, Berger-Bachi B, Projan S. 2004. Microarray-based analysis of the Staphylococcus aureus σB regulon. J Bacteriol 186:4085–4099. doi: 10.1128/JB.186.13.4085-4099.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Pane-Farre J, Jonas B, Forstner K, Engelmann S, Hecker M. 2006. The σB regulon in Staphylococcus aureus and its regulation. Int J Med Microbiol 296:237–258. doi: 10.1016/j.ijmm.2005.11.011. [DOI] [PubMed] [Google Scholar]
  • 36.Christian JH, Waltho JA. 1961. The sodium and potassium content of non-halophilic bacteria in relation to salt tolerance. J Gen Microbiol 25:97–102. doi: 10.1099/00221287-25-1-97. [DOI] [PubMed] [Google Scholar]
  • 37.Bayer AS, McNamara P, Yeaman MR, Lucindo N, Jones T, Cheung AL, Sahl HG, Proctor RA. 2006. Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1. J Bacteriol 188:211–222. doi: 10.1128/JB.188.1.211-222.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Clauditz A, Resch A, Wieland KP, Peschel A, Gotz F. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74:4950–4953. doi: 10.1128/IAI.00204-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AH, Oldfield E. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319:1391–1394. doi: 10.1126/science.1153018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Marshall JH, Wilmoth GJ. 1981. Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids. J Bacteriol 147:900–913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Price-Whelan A, Poon CK, Benson MA, Eidem TT, Roux CM, Boyd JM, Dunman PM, Torres VJ, Krulwich TA. 2013. Transcriptional profiling of Staphylococcus aureus during growth in 2 M NaCl leads to clarification of physiological roles for Kdp and Ktr K+ uptake systems. mBio 4:e00407-13. doi: 10.1128/mBio.00407-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. MBio 4:e00537-12. doi: 10.1128/mBio.00537-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Highlander SK, Hultén KG, Qin X, Jiang H, Yerrapragada S, Mason EO Jr, Shang Y, Williams TM, Fortunov RM, Liu Y, Igboeli O, Petrosino J, Tirumalai M, Uzman A, Fox GE, Cardenas AM, Muzny DM, Hemphill L, Ding Y, Dugan S, Blyth PR, Buhay CJ, Dinh HH, Hawes AC, Holder M, Kovar CL, Lee SL, Liu W, Nazareth LV, Wang Q, Zhou J, Kaplan SL, Weinstock GM. 2007. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol 7:99. doi: 10.1186/1471-2180-7-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ruzin A, Lindsay J, Novick RP. 2001. Molecular genetics of SaPI1—a mobile pathogenicity island in Staphylococcus aureus. Mol Microbiol 41:365–377. doi: 10.1046/j.1365-2958.2001.02488.x. [DOI] [PubMed] [Google Scholar]
  • 45.Kuroda M, Ohta T, Hayashi H. 1995. Isolation and the gene cloning of an alkaline shock protein in methicillin resistant Staphylococcus aureus. Biochem Biophys Res Commun 207:978–984. doi: 10.1006/bbrc.1995.1281. [DOI] [PubMed] [Google Scholar]
  • 46.Bae T, Banger AK, Wallace A, Glass EM, Aslund F, Schneewind O, Missiakas DM. 2004. Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci U S A 101:12312–12317. doi: 10.1073/pnas.0404728101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Chaudhuri RR, Allen AG, Owen PJ, Shalom G, Stone K, Harrison M, Burgis TA, Lockyer M, Garcia-Lara J, Foster SJ, Pleasance SJ, Peters SE, Maskell DJ, Charles IG. 2009. Comprehensive identification of essential Staphylococcus aureus genes using transposon-mediated differential hybridisation (TMDH). BMC Genomics 10:291. doi: 10.1186/1471-2164-10-291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Christiansen MT, Kaas RS, Chaudhuri RR, Holmes MA, Hasman H, Aarestrup FM. 2014. Genome-wide high-throughput screening to investigate essential genes involved in methicillin-resistant Staphylococcus aureus sequence type 398 survival. PLoS One 9:e89018. doi: 10.1371/journal.pone.0089018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ji Y, Zhang B, Van SF, Horn Warren P, Woodnutt G, Burnham MK, Rosenberg M. 2001. Identification of critical Staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293:2266–2269. doi: 10.1126/science.1063566. [DOI] [PubMed] [Google Scholar]
  • 50.Valentino MD, Foulston L, Sadaka A, Kos VN, Villet RA, Santa Maria J Jr, Lazinski DW, Camilli A, Walker S, Hooper DC, Gilmore MS. 2014. Genes contributing to Staphylococcus aureus fitness in abscess- and infection-related ecologies. mBio 5:e01729-14. doi: 10.1128/mBio.01729-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ito M, Guffanti AA, Wang W, Krulwich TA. 2000. Effects of nonpolar mutations in each of the seven Bacillus subtilis mrp genes suggest complex interactions among the gene products in support of Na+ and alkali but not cholate resistance. J Bacteriol 182:5663–5670. doi: 10.1128/JB.182.20.5663-5670.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Finn RD, Bateman A, Clements J, Coggill P, Eberhardt RY, Eddy SR, Heger A, Hetherington K, Holm L, Mistry J, Sonnhammer EL, Tate J, Punta M. 2014. Pfam: the protein families database. Nucleic Acids Res 42:D222–D230. doi: 10.1093/nar/gkt1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Arnaud M, Chastanet A, Debarbouille M. 2004. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol 70:6887–6891. doi: 10.1128/AEM.70.11.6887-6891.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Memmi G, Filipe SR, Pinho MG, Fu Z, Cheung A. 2008. Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob Agents Chemother 52:3955–3966. doi: 10.1128/AAC.00049-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Horton RM. 1993. In vitro recombination and mutagenesis of DNA: SOEing together tailor-made genes. Methods Mol Biol 15:251–261. [DOI] [PubMed] [Google Scholar]
  • 56.Liu J, Ryabichko S, Bogdanov M, Fackelmayer OJ, Dowhan W, Krulwich TA. 2014. Cardiolipin is dispensable for oxidative phosphorylation and non-fermentative growth of alkaliphilic Bacillus pseudofirmus OF4. J Biol Chem 289:2960–2971. doi: 10.1074/jbc.M113.536193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Morino M, Natsui S, Swartz TH, Krulwich TA, Ito M. 2008. Single gene deletions of mrpA to mrpG and mrpE point mutations affect activity of the Mrp Na+/H+ antiporter of alkaliphilic Bacillus and formation of hetero-oligomeric Mrp complexes. J Bacteriol 190:4162–4172. doi: 10.1128/JB.00294-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Alonzo F III, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ. 2012. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 83:423–435. doi: 10.1111/j.1365-2958.2011.07942.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R, Olson PD, Projan SJ, Dunman PM. 2006. Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J Bacteriol 188:6739–6756. doi: 10.1128/JB.00609-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Wang D, Yu L, Xiang H, Fan J, He L, Guo N, Feng H, Deng X. 2008. Global transcriptional profiles of Staphylococcus aureus treated with berberine chloride. FEMS Microbiol Lett 279:217–225. doi: 10.1111/j.1574-6968.2007.01031.x. [DOI] [PubMed] [Google Scholar]
  • 61.Anderson KL, Roux CM, Olson MW, Luong TT, Lee CY, Olson R, Dunman PM. 2010. Characterizing the effects of inorganic acid and alkaline shock on the Staphylococcus aureus transcriptome and messenger RNA turnover. FEMS Immunol Med Microbiol 60:208–250. doi: 10.1111/j.1574-695X.2010.00736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Delgado A, Zaman S, Muthaiyan A, Nagarajan V, Elasri MO, Wilkinson BJ, Gustafson JE. 2008. The fusidic acid stimulon of Staphylococcus aureus. J Antimicrob Chemother 62:1207–1214. doi: 10.1093/jac/dkn363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Beenken KE, Dunman PM, McAleese F, Macapagal D, Murphy E, Projan SJ, Blevins JS, Smeltzer MS. 2004. Global gene expression in Staphylococcus aureus biofilms. J Bacteriol 186:4665–4684. doi: 10.1128/JB.186.14.4665-4684.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. 2002. σB Modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184:5457–5467. doi: 10.1128/JB.184.19.5457-5467.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Duthie ES, Lorenz LL. 1952. Staphylococcal coagulase; mode of action and antigenicity. J Gen Microbiol 6:95–107. [DOI] [PubMed] [Google Scholar]
  • 66.Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731–739. doi: 10.1016/S0140-6736(06)68231-7. [DOI] [PubMed] [Google Scholar]
  • 67.McDougal LK. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41:5113–5120. doi: 10.1128/JCM.41.11.5113-5120.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. doi: 10.1371/journal.pone.0010146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Novick RP. 1991. Genetic systems in staphylococci. Methods Enzymol 204:587–636. doi: 10.1016/0076-6879(91)04029-N. [DOI] [PubMed] [Google Scholar]
  • 70.Nozaki K, Inaba K, Kuroda T, Tsuda M, Tsuchiya T. 1996. Cloning and sequencing of the gene for Na+/H+ antiporter of Vibrio parahaemolyticus. Biochem Biophys Res Commun 222:774–779. doi: 10.1006/bbrc.1996.0820. [DOI] [PubMed] [Google Scholar]
  • 71.Hanahan D. 1985. Techniques for transformation of E. coli, p 109–135. In Glover DM. (ed), DNA cloning: a practical approach, vol. 1. IRL Press, Washington, DC. [Google Scholar]
  • 72.Simonet JM, Boccard F, Pernodet JL, Gagnat J, Guérineau M. 1987. Excision and integration of a self-transmissible replicon of Streptomyces ambofaciens. Gene 59:137–144. doi: 10.1016/0378-1119(87)90274-5. [DOI] [PubMed] [Google Scholar]
  • 73.Chen J, Yoong P, Ram G, Torres VJ, Novick RP. 2014. Single-copy vectors for integration at the SaPI1 attachment site for Staphylococcus aureus. Plasmid 76:1–7. doi: 10.1016/j.plasmid.2014.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES